Target type: biologicalprocess
Any process that activates or increases the frequency, rate or extent of chemokine (C-X-C motif) ligand 1 production. [GOC:BHF, GOC:mah]
Positive regulation of chemokine (C-X-C motif) ligand 1 (CXCL1) production is a complex biological process involving multiple signaling pathways and cellular mechanisms. CXCL1, also known as GROα, is a pro-inflammatory chemokine that plays a crucial role in attracting neutrophils to sites of inflammation and tissue injury.
**1. Induction of CXCL1 Gene Transcription:**
* **NF-κB Pathway:** Activation of the NF-κB pathway is a primary mechanism for inducing CXCL1 expression. This pathway can be triggered by a variety of stimuli, including bacterial lipopolysaccharide (LPS), tumor necrosis factor-alpha (TNF-α), and interleukin-1 (IL-1). Upon activation, NF-κB translocates to the nucleus and binds to specific DNA sequences in the CXCL1 gene promoter, leading to increased gene transcription.
* **MAPK Pathways:** Mitogen-activated protein kinases (MAPKs) are another critical signaling cascade involved in CXCL1 regulation. Specifically, the JNK and p38 MAPK pathways have been shown to activate the CXCL1 promoter through phosphorylation of transcription factors like c-Jun and ATF-2.
* **Other Transcription Factors:** Several other transcription factors besides NF-κB and MAPK-related factors can modulate CXCL1 expression, including STATs, AP-1, and C/EBPs. Their activation depends on the specific stimuli and cellular context.
**2. Post-Transcriptional Regulation:**
* **mRNA Stability:** CXCL1 mRNA stability can be regulated by a variety of factors, including microRNAs and RNA-binding proteins. These regulatory mechanisms can influence the half-life of CXCL1 mRNA, thereby affecting CXCL1 protein production.
* **Translation:** Translation of CXCL1 mRNA into protein is also subject to regulation. Factors like ribosomal availability and the presence of specific translation initiation factors can influence the efficiency of CXCL1 protein synthesis.
**3. Post-Translational Modification:**
* **Glycosylation:** CXCL1 can undergo glycosylation, a process that adds sugar molecules to the protein. Glycosylation can influence the stability, activity, and interactions of CXCL1.
* **Proteolytic Processing:** In some cases, CXCL1 may be cleaved by proteases, resulting in the production of shorter, active forms of the chemokine.
**4. Cellular Release:**
* **Secretion:** CXCL1 is typically secreted from cells via the endoplasmic reticulum-Golgi secretory pathway. This process involves packaging CXCL1 into vesicles and releasing it into the extracellular space.
**Overall, the regulation of CXCL1 production is a tightly controlled process that involves a complex interplay of signaling pathways, transcription factors, post-transcriptional and post-translational modifications, and cellular secretion mechanisms. These factors work together to ensure appropriate levels of CXCL1 are produced in response to inflammatory stimuli, ultimately promoting neutrophil recruitment and inflammation resolution.'
"
Protein | Definition | Taxonomy |
---|---|---|
Transient receptor potential cation channel subfamily V member 4 | A transient receptor potential cation channel TRPV4 that is encoded in the genome of human. [PRO:CNA, UniProtKB:Q9HBA0] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
cannabinol | Cannabinol: A physiologically inactive constituent of Cannabis sativa L. | dibenzopyran | |
cannabichromene | 1-benzopyran | ||
(6ar-trans)-isomer of tetrahydrocannabivarin 9 | |||
hc 030031 | 2-(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)-N-(4-isopropylphenyl)acetamide: a TRPA1 channel blocker | ||
hc-067047 | HC-067047: a TRPA1 antagonist; structure in first source | ||
rn 1734 | RN 1734: a TRPV4 antagonist; structure in first source | ||
cannabigerol | cannabigerol : A member of the class of resorcinols that is resorcinol which is substituted by a (2E)-3,7-dimethylocta-2,6-dien-1-yl group at position 2 and by a pentyl group at position 5. It is a natural product found in Cannabis sativa and Helichrysum species. cannabigerol: RN given refers to (E)-isomer; structure given in first source | phytocannabinoid; resorcinols | anti-inflammatory agent; antibacterial agent; antioxidant; appetite enhancer; cannabinoid receptor agonist; neuroprotective agent; plant metabolite |
cannabidivarin | cannabidivarin: from Cannabis sativa | monoterpenoid | |
gsk 1016790a | GSK1016790A : A tertiary carboxamide that is piperazine in which one of the amino groups has undergone condensation with the carboxy group of N-[(2,4-dichlorophenyl)sulfonyl]-L-serine, while the other has undergone condensation with the carboxy group of N-(1-benzothiophen-2-ylcarbonyl)-L-leucine. It is a cell-permeable, potent and selective agonist of the TRPV4 (transient receptor potential vanilloid 4) channel. | 1-benzothiophenes; aromatic primary alcohol; dichlorobenzene; N-acylpiperazine; sulfonamide; tertiary carboxamide | TRPV4 agonist |